Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
W9gxBFSPytW22e8C
